Universidad de Santander: Clinical Trials

14 trials sponsored by Universidad de Santander, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 5 unknown, 1 not yet recruiting, 1 recruiting. 7 Not applicable, 3 Phase 3, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable7Unknown 4, Completed 1, Not yet recruiting 1, Recruiting 1
Phase 33Completed 2, Terminated 1
Phase 21Completed 1
Phase 41Unknown 1

Follow Universidad de Santander: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Online Mindfulness Therapy on Pain and Stress in Adults With Chronic Migraine and Adverse Childhood Experiences
Online Mindfulness-Based Cognitive Therapy - Chronic Migraine, Adverse Childhood Experiences
Not applicableNot yet recruitingFundación Cardiovascular de Colombia602025-07-012025-06-26
Efficacy of a Multicomponent Intervention on Cognitive Function for the Caregiver-patient Dyad
Multi-component, transdisciplinary and multifocal intervention for the cognition - Mild Cognitive Impairment
Not applicableRecruitingUniversidad de Santander1022024-07-302026-05-07
Caribbean and South America Team-based Strategy to Control Hypertension
Team-based Care to Implement Single-Pill Combination Therapy, Enhanced Usual Care - Hypertension, Blood Pressure
Phase 3CompletedTulane University17062023-02-232026-10-01
Efficacy of a Multicomponent and Interdisciplinary Intervention on the Care Ability and Burden of Family Caregivers of People With Chronic Cardiocerebrovascular Diseases
Intervention group: Educational Intervention "KARER" - Caregivers, Burnout, Psychological
Not applicableUnknownClaudia Aristizábal842021-03-082021-10-14
Health Care Workers' Perception of Patient Safety During COVID-19 Pandemic
Group 1 - Patient Safety
CompletedUniversidad Miguel Hernandez de Elche2602020-09-012022-09-19
FEnofibRate as a Metabolic INtervention for COVID-19
Fenofibrate/fenofibric acid, Placebo, Usual care - Covid19
Phase 2CompletedUniversity of Pennsylvania7012020-08-182023-03-24
Needs, Perceptions and Acute Stress of Healtcare Workers Caring for COVID-19 Patients in South America
Online survey - Acute Stress Disorder
CompletedUniversidad Miguel Hernandez de Elche18002020-04-012022-09-19
Adherence to the Transition-discharge-hospital Plan in Patient-family Caregiver With Chronic Pathology
The intervention with the patient (Chronic Patient Care Group and his family.) - Treatment Adherence and Compliance
Not applicableUnknownUniversidad de Santander1002019-11-302019-11-25
Delirium Prevention in Patients From the Intensive Care Unit (DELA)
Delirium prevention program - Hypoactive Delirium, Hyperactive Delirium
Not applicableUnknownUniversidad de Santander2002017-10-012017-10-27
Effectiveness Program Caregivers Care
Educative intervention: - Chronic Disease
Not applicableUnknownUniversidad de Santander1002017-06-152019-11-22
Resistance and Aerobic Training, Relationship With Birth Weight in Colombian Children
Muscular Resistance training, Cardiorespiratory training, Habitual training - Resistance Training, Cardiovascular Risk
Not applicableCompletedFundación Oftalmológica de Santander Clínica Carlos Ardila Lulle1502016-02-012018-12-27
Trial of Supplementation With Aged Garlic Extract to Improve Endothelial Function in Patients With Metabolic Syndrome
aged garlic extract, Placebo - Metabolic Syndrome
Phase 4UnknownUniversidad de Santander462009-11-012010-07-23
Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
controlled nitric oxide releasing patch, meglumine antimoniate - Cutaneous Leishmaniasis
Phase 3TerminatedFundación Cardiovascular de Colombia1782006-05-012010-11-24
Clinical Trial for the Treatment of Diabetic Foot Ulcers Using a Nitric Oxide Releasing Patch: PATHON
Controlled nitric oxide releasing patch, placebo patch - Diabetic Foot
Phase 3CompletedFundación Cardiovascular de Colombia1002005-01-012012-11-06

Conditions studied

COVID-19 (2)  ·  Anxiety Disorders (1)  ·  Burnout, Psychological (1)  ·  Cerebrovascular Disorders (1)  ·  Chronic Disease (1)  ·  Cognitive Dysfunction (1)  ·  Delirium (1)  ·  Depression (1)  ·  Diabetic Foot (1)  ·  Headache (1)  ·  Headache Disorders (1)  ·  Health Education (1)  ·  Hypertension (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)

Interventions

Fenofibrate (1)  ·  Meglumine Antimoniate (1)  ·  fenofibric acid (1)  ·  kyolic (1)

Countries

Colombia (12)  ·  Chile (2)  ·  Ecuador (2)  ·  Spain (2)  ·  Argentina (1)  ·  Jamaica (1)  ·  United States (1)

Top investigators

Christian F Rueda-Clausen, MD (2)  ·  Claudia C Torres, RN, MSc (2)  ·  Daniel J Smith, PhD (2)  ·  Federico A Silva, MD (2)  ·  Jose J Mira, PhD (2)  ·  Ligia C Rueda, MD (2)  ·  Arturo Orduz, MD (1)  ·  Carlos A Calderon, PhD (1)  ·  Daniel Smith, PhD (1)  ·  Diana Tiga Loza (1)  ·  Elkin Rene Llanez Anaya, MD, Psychiatrist. (1)

Results publications

PMID 17897470, PMID 33175877, PMID 34755800, PMID 35589975, PMID 35982675, PMID 36344766, PMID 41419163, PMID 42365385